Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage
pharmaceutical company focused on the discovery, development and
commercialization of first-in-class glaucoma therapies, today reported
financial results for second quarter 2014 and provided an update on the
Company’s business highlights.
for Aerie Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Business and Product Development Update investment picks